Copyright © 2004, European Society of Cardiology
Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels
Department of Medical Physiology, University Medical Center Utrecht, P.O. Box 85060, 3508 AB Utrecht, The Netherlands
* Corresponding author. Tel.: +31 30 2538900; fax: +31 30 2539036. Email address: m.a.g.vanderheyden{at}med.uu.nl
L-type Ca2+ channels are predominantly regulated by β-adrenergic stimulation, enhancing L-type Ca2+ current by increasing the mean channel open time and/or the opening probability of functional Ca2+ channels. Stimulation of β-adrenergic receptors (ARs) results in an increased cyclic adenosine monophosphate (cAMP) production by adenylate cyclase (AC) and consequently activation of protein kinase (PK) A and phosphorylation of L-type Ca2+ channels by this enzyme. β1-Adrenergic receptors couple exclusively to the G protein Gs, producing a widespread increase in cAMP levels in the cell, whereas β2-adrenergic receptors couple to both Gs and Gi, producing a more localized activation of L-type Ca2+ channels. Other signaling intermediates (protein kinase C, protein kinase G or protein tyrosine kinase (PTK)) either have negative effects on L-type Ca2+ current, or they interact with the stimulatory effect of the protein kinase A pathway.
KEYWORDS Adrenergic (ant)agonists; Ca-channel; Ca (cellular); G-proteins; Protein kinase A; Protein kinase C; Protein kinase G; Protein phosphatase; Protein phosphorylation; Second messengers; Tyrosine protein kinase
Abbreviations: AR, adrenergic receptor • AC, adenylate cyclase • AKAP, A kinase anchoring protein • ATP, adenosine triphosphate • Ca2+, calcium • cAMP, cyclic adenosine monophosphate • cGMP, cyclic guanosine monophosphate • DAG, 1,2-diacylglycerol • GC, guanylate cyclase • G protein, guanosine 5'-triphosphate (GTP)-binding protein • GSNO, nitrosoglutathione • ICa-L, L-type Ca2+ current • InsP3, inositol 1,4,5-triphosphate • NO, nitric oxide • PIP2, phosphatidylinositol 4,5-biphosphate • PK, protein kinase • PLC, phospholipase C • PTK, protein tyrosine kinase • Ser, serine • Thr, threonine
Time for primary review 20 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Grote-Wessels, H. A. Baba, P. Boknik, A. El-Armouche, L. Fabritz, H.-J. Gillmann, D. Kucerova, M. Matus, F. U. Muller, J. Neumann, et al. Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload Cardiovasc Res, August 1, 2008; 79(3): 464 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Mangoni and J. Nargeot Genesis and Regulation of the Heart Automaticity Physiol Rev, July 1, 2008; 88(3): 919 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Maturana, S. Walchli, M. Iwata, S. Ryser, J. Van Lint, M. Hoshijima, W. Schlegel, Y. Ikeda, K. Tanizawa, and S. Kuroda Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel Cardiovasc Res, June 1, 2008; 78(3): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Mallet Hypoxic modulation of cardiac L-type Ca2+ current: Interaction of reactive oxygen species and {beta}-adrenergic signaling Cardiovasc Res, September 1, 2005; 67(4): 578 - 580. [Full Text] [PDF]
|
|